中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
21期
3214-3215
,共2页
直肠肿瘤%腹腔镜检查%直肠结肠切除术,重建性%结肠系膜
直腸腫瘤%腹腔鏡檢查%直腸結腸切除術,重建性%結腸繫膜
직장종류%복강경검사%직장결장절제술,중건성%결장계막
Rectal Neoplasms%Laparoscopy%Proctocolectomy,restorative%Mesocolon
目的 探讨保肛根治术治疗直肠癌的临床疗效.方法 直肠癌患者35例,均经病理组织学检查确诊.所有患者均采用腹腔镜下直肠癌保肛根治术,术后常规化疗.随访时间3年,观察患者手术时间、术中出血量、术中及术后并发症、术后恢复情况、死亡情况等.结果 患者手术均顺利完成,切除肠管边缘均未发现肿瘤细胞.手术时间(171.74±58.24) min,术中出血量(85.74±68.32) ml,均未发生感染、出血、吻合口破裂及狭窄等并发症.经2~3年随访,1例患者于术后5月出现肝脏转移,其余患者均健在,无原位复发,无大便失禁,无死亡病例.结论 保肛根治术治疗直肠癌具有较好的疗效,并能够改善患者生活质量.
目的 探討保肛根治術治療直腸癌的臨床療效.方法 直腸癌患者35例,均經病理組織學檢查確診.所有患者均採用腹腔鏡下直腸癌保肛根治術,術後常規化療.隨訪時間3年,觀察患者手術時間、術中齣血量、術中及術後併髮癥、術後恢複情況、死亡情況等.結果 患者手術均順利完成,切除腸管邊緣均未髮現腫瘤細胞.手術時間(171.74±58.24) min,術中齣血量(85.74±68.32) ml,均未髮生感染、齣血、吻閤口破裂及狹窄等併髮癥.經2~3年隨訪,1例患者于術後5月齣現肝髒轉移,其餘患者均健在,無原位複髮,無大便失禁,無死亡病例.結論 保肛根治術治療直腸癌具有較好的療效,併能夠改善患者生活質量.
목적 탐토보항근치술치료직장암적림상료효.방법 직장암환자35례,균경병리조직학검사학진.소유환자균채용복강경하직장암보항근치술,술후상규화료.수방시간3년,관찰환자수술시간、술중출혈량、술중급술후병발증、술후회복정황、사망정황등.결과 환자수술균순리완성,절제장관변연균미발현종류세포.수술시간(171.74±58.24) min,술중출혈량(85.74±68.32) ml,균미발생감염、출혈、문합구파렬급협착등병발증.경2~3년수방,1례환자우술후5월출현간장전이,기여환자균건재,무원위복발,무대편실금,무사망병례.결론 보항근치술치료직장암구유교호적료효,병능구개선환자생활질량.
Objective To investigate the clinical efficacy of rectal resection for rectal cancer.Methods 35 patients with rectal cancer were diagnosed by pathological examination.They were treated with laparoscopic rectal cancer resection and conventional chemotherapy.The patients were followed up for 3 years.The operative time,blood loss,intraoperative and postoperative complications,postoperative recovery,death and so on were observed.Results The patients were operated successfully,and no tumor cells were found in the bowel edge.The average operative time was (171.74 ± 58.24) min,average blood loss was (85.74 ± 68.32) ml,there were no infection,bleeding,anastomotic complications.After 2 ~ 3 years of follow-up,there was 1 patient with liver metastases,and no local recurrence,no fecal incontinence and no deaths.Conclusion Rectal resection for rectal cancer had good effect and could improve patients' quality of life.